Clinical Trials Logo

Filter by:
NCT ID: NCT04593004 Completed - Acne Vulgaris Clinical Trials

Teledermatology vs. Face-to-Face Visits in the Follow-Up of Patients With Acne

Start date: October 7, 2020
Phase: N/A
Study type: Interventional

Acne vulgaris is a common cutaneous inflammatory condition of sebaceous follicles that can profoundly affect patients' quality of life, especially at a young age. In this context the use of teledermatology can potentially reduce the healthcare costs associated to traditional consultations as well as the costs related to travel and loss of school/working time for the patient, with a clear benefit for the whole community. Since 2016, the Department of Dermatology at Inselspital Hospital in Bern has a portal and a smartphone app for online advice service. Hereby the investigators propose to explicitly investigate the efficacy of this system in reducing healthcare costs as compared to traditional face-to-face consultations, in a cohort of patients with mild-to-moderate acne vulgaris.

NCT ID: NCT04590898 Completed - Stroke Clinical Trials

Peri-device Leakage Closure After LAAO

Start date: September 27, 2020
Phase:
Study type: Observational

The investigators thought to evaluate the safety and feasibility of peri-device leakage closure after left atrial appendage occlusion (LAAO, either surgical or interventional) with different devices.

NCT ID: NCT04589962 Completed - Clinical trials for Surgical and the Percutaneous Approach to the Upper Extremity Access

SUrgical Versus PERcutaneous AXillary Artery International Registry

Start date: October 9, 2020
Phase:
Study type: Observational

The purpose of the Study is to compare the outcomes of the surgical and the percutaneous approach to the upper extremity access (axillary or brachial artery) during endovascular procedures on the aortic valve, the aorta, and its side branches.

NCT ID: NCT04589481 Completed - Bad Breath Clinical Trials

Effectiveness of Different Candies Against Bad Breath

HALIDROP
Start date: February 23, 2021
Phase: N/A
Study type: Interventional

This study is to analyze whether the candies can relieve or eliminate bad breath, both subjectively and objectively.

NCT ID: NCT04585854 Completed - Caffeine Clinical Trials

Effect of Caffeine on Myocardial Oxygenation

Coffee-O2
Start date: November 13, 2020
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate the impact of caffeine on myocardial oxygenation and other cardiovascular magnetic resonance parameters in healthy controls.

NCT ID: NCT04581135 Completed - COVID-19 Clinical Trials

Study to Investigate Long-term Pulmonary and Extrapulmonary Effects of COVID-19

Start date: May 1, 2020
Phase:
Study type: Observational [Patient Registry]

Prospective Observational Swiss Cohort Study to Investigate Long-term Pulmonary and Extrapulmonary Effects of COVID-19.

NCT ID: NCT04579055 Completed - Clinical trials for Chronic Obstructive Pulmonary Disease

Impact of Chair Seat Height on the 1-Minute Sit to Stand Test Performance in Chronic Obstructive Pulmonary Disease

Start date: September 16, 2020
Phase: N/A
Study type: Interventional

The 1-minute sit to stand (1-min STS) test is a standardized test which is used to examine exercise capacity in patients with chronic obstructive pulmonary disease (COPD). The chair seat height used is standardized to 46-48 cm. Using a standard seat height for all patients - irrespective of their body height - may lead to invalid estimates of functional exercise capacity. The objective of this study is to assess whether there is a difference in repetitions during the 1-min STS test if the seat height is adjusted to 90° knee joint angle or the standard height chair of 46 cm is used.

NCT ID: NCT04578457 Completed - Hearing Loss Clinical Trials

Assessment of Novel Sound Changing Principles in Hearing Instruments to Determine Their Application - 2020_09

Start date: October 23, 2020
Phase: N/A
Study type: Interventional

Participants will perform two different listening tasks: (1) listening to, and repeating back, sentence lists presented in noise, and (2) Subjective rating of effort & performance following each condition. During this study, continuous, non-invasive physiological measurements (skin conductance, changes in pupil dilation) will be recorded from participants. Using this paradigm we will be assessing the effect of different hearing aid processing algorithms on listening effort. The study takes the form of a one factor (algorithm), within-subjects design. Each participant performs the Speech perception task with each algorithm (reference, noise reduction I, noise reduction II, noise reduction III), at two individualized signal-to-noise ratios (SRT90 and SRT50). Additionally subjective performance ratings in real-life will be collected.

NCT ID: NCT04577989 Completed - Clinical trials for Infection With AmpC Beta-lactamase Producing Enterobacterales

Clinical Comparison of Treatment Strategies in AmpC Beta-lactamase Producing Enterobacterales in a Swiss Tertiary Care Hospital

AmpCstratBasel
Start date: December 14, 2020
Phase:
Study type: Observational

This study is to investigate the recent epidemiological trends and the treatment outcome in terms of the length of hospital stay, the relevant renal and neurological side effects, risk factors for developing these side effects, the selection of more resistant pathogens under therapy as well as the incidence of Clostridium difficile infections under treatment.

NCT ID: NCT04576988 Completed - Clinical trials for Pulmonary Arterial Hypertension

A Study of Sotatercept for the Treatment of Pulmonary Arterial Hypertension (MK-7962-003/A011-11)(STELLAR)

Start date: January 25, 2021
Phase: Phase 3
Study type: Interventional

The objectives of this study are to evaluate the efficacy and safety of sotatercept (MK-7962) treatment (plus background pulmonary arterial hypertension (PAH) therapy) versus placebo (plus background PAH therapy) at 24 weeks in adults with PAH. The primary hypothesis of the study is that the participants receiving sotatercept will have improved 6-minute walk distance (6MWD) at 24 weeks compared to participants receiving placebo.